A novel blood serum assay to diagnose neurodegenerative diseases

Scientists have developed a new assay that can identify specific neurodegenerative diseases by detecting abnormal α-synuclein in patient sera

2023-05-29

(Press-News.org)

Synucleinopathies are a group of neurodegenerative diseases caused by the abnormal accumulation α-synuclein, a protein normally found in the brain and neurons. Incorrect folding of α-synuclein leads to formation of ‘seeds’, which attract more α-synuclein proteins to form larger clumps. Although, α-synuclein seeds have been found in various tissues and blood of patients with synucleinopathies, its potential as a biomarker is ambiguous.

Recently, in a study published in Nature Medicine, Associate Professor Ayami Okuzumi along with Senior Associate Professor Taku Hatano, both from the Juntendo University School of Medicine, Senior Assistant Professor Gen Matsumoto at the Nagasaki University School of Medicine, and Professor Nobutaka Hattori from Juntendo University Faculty of Medicine /RIKEN Center for Brain Science, present a novel assay that can efficiently detect α-synuclein seeds from a patient’s serum.

In this assay, named immunoprecipitation-based real-time quaking-induced conversion (IP/RT-QuIC), the α-synuclein seeds are isolated from the patient’s serum through immunoprecipitation (protein separation using an antibody binding only to the target protein) followed by rapid amplification by real-time quaking-induced conversion (amplification induced by vigorous shaking). This method is highly sensitive, as it can detect serum α-synuclein seed concentrations as small as 1000pg/ml. This comes as great news since most existing diagnostic methods require cerebrospinal fluid for synuclein detection. The current study was made available/published on May 30, 2023.

Sharing the objective of their study, Professor Hattori and his team explains, “In this study, we validated the usefulness of our novel assay system, IP/RT-QuIC, as a diagnostic marker of synucleinopathies. We propose that the fibril morphology of serum α-synuclein seeds and aggregates derived by IP/RT-QuIC can discriminate between Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).”

The research team demonstrated that IP/RT-QuIC detected α-synuclein seeds efficiently in patients with neurodegenerative diseases and could distinguish them from people without degenerative diseases (controls). Next, they studied the structural properties of the amplified seeds using transmission electron microscopy (TEM). They observed that the synuclein seed structure varied with the type of synucleinopathy. PD and DLB seeds showed paired filaments whereas MSA seeds had two distinct structures – twisted and straight filaments. This finding was confirmed that IP/RT-QuIC coupled with TEM can differentiate between synucleinopathies based on disease specific seed structure.

Further, when the researchers transduced amplified seeds into the HEK293T cell line stably expressing GFP-fused human α-synuclein with p.A53T mutation (in vitro) and injected seeds into mouse brains (in vivo), the seeds retained their aggregate forming capacity and diseases-specific seed structure. These aggregates displayed different morphologies depending on the disease type. Thus, specific synucleinopathies can be diagnosed by IP/RT-QuIC from the structural differences of the α-synuclein seeds and their aggregates.

This technique could help provide a quick and efficient diagnosis to patients. Professor Hattori and his team explains, “At present, a neurologist's consultation is necessary to diagnose synucleinopathies. However, using IP/RTQuIC, a general internist can make the diagnosis. Therefore, more patients with synucleinopathies may be diagnosed with precision and could receive appropriate treatment at an earlier stage.”

The authors conclude with their future vision, “Our new IP/RT-QuIC assay may have many future applications as a biomarker for precise diagnosis and monitoring of treatment of neurodegenerative diseases in clinical trials. This simple diagnostic method will enable establishment of personalized therapy options for synucleinopathies.”

Reference

Authors

Ayami Okuzumi1, Taku Hatano1, Gen Matsumoto2, Shuko Nojiri3, Shin-ich Ueno1, Yoko Imamichi1, Haruka Kimura1, Soichiro Kakuta4, Akihide Kondo5, Takeshi Fukuhara6, Yuanzhe Li1, Manabu Funayama1, Shinji Saiki1, Daisuke Taniguchi1, Taiji Tsunemi1, Deborah McIntyre7, Jean-Jacques Gérardy8, Michel Mittelbronn8, Rejko Krüger7, Yasuo Uchiyama9, Nobuyuki Nukina10, and Nobutaka Hattori1, 6

Title of original paper

Propagative α-synuclein seeds in the serum of patients with synucleinopathies

Journal

Nature Medicine

DOI

10.1038/s41591-023-02358-9

Affiliations

1Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

2Department of Histology and Cell Biology, Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan

3Medical Technology Innovation Center, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

4Laboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

5The Department of Neurosurgery, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

6Neurodegenerative Disorders Collaboration Laboratory, RIKEN Center for Brain Science, Saitama 351-0198, Japan

7Transversal Translational Medicine, Luxemburg Institute of Health (LIH); Centre Hospitalier de Luxemburg (CHL), Luxemburg; Translational Neuroscience, Luxemburg Centre for Systems Biomedicine (LCSB), University of Luxemburg

8Luxemburg National Center of Pathology (NCP), Laboratoire National de Sante (LNS), Dudelange, Luxemburg; Department of Cancer Research (DOCR), Luxemburg Institute of Health (LIH); Luxemburg Center of Neuropathology (LCNP), Luxemburg Centre for Systems Biomedicine (LCSB) Faculty of Science, Technology and Medicine (FSTM), and Department of Life Science and Medicine (DLSM), University of (LCSB)

9Department of Cell Biology and Neuroscience, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

10Laboratory of Structural Neuropathology, Graduate School of Brain Science, Doshisha University, Kyoto 602-8580, Japan

Additional information for EurekAlert

ELSE PRESS RELEASES FROM THIS DATE:

Study reveals underlying genetic risks for a type of heart attack largely affecting younger women

2023-05-29

Research led by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC) and Universite Paris Cite, and supported by worldwide partners in Canada, the USA and Australia, has identified new genes that are associated with an increased risk of a type of heart attack primarily affecting young to middle-aged women. The results are published in Nature Genetics today, 29 May 2023. SCAD – or Spontaneous Coronary Artery Dissection – is when a bruise or bleed occurs in the wall of a coronary artery, cutting off the blood to part of the heart. This leads to a heart attack. Unlike other types of heart attack, SCAD ...

Pan-cancer T cell atlas reveals new details of tumor microenvironment

2023-05-29

HOUSTON ― A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides a deeper understanding of the vast diversity of T cell states as well as their relationships and roles within the complex tumor microenvironment, bringing a fresh perspective to understanding immunotherapy efficacy in cancer. This new pan-cancer single-cell T cell atlas integrates 27 single-cell RNA sequencing datasets, including nine unique datasets from MD Anderson, covering 16 cancer types. It is the most detailed picture to date of the heterogeneity ...

KRISS ushers in era of green hydrogen

2023-05-29

Hydrogen has been gaining attention as a clean and efficient energy source. However, is hydrogen really environmentally friendly? Most hydrogen commonly used now is “grey hydrogen” derived from fossil fuels. Since its production process accompanies generation of green house gas, it can be said that grey hydrogen is not environmentally friendly in the strict sense. The era of “green hydrogen” without carbon emissions has not yet begun. The Korea Research Institute of Standards and Science (KRISS, President Hyun-min Park) has demonstrated the key to the longevous and efficient photoanode with protective film, which is used to produce hydrogen ...

How excessive salt consumption is linked to cognitive disorders and high blood pressure

2023-05-29

Dementia is defined as the loss of cognitive functioning—including thinking, remembering, and reasoning—and is very prevalent in Japan. Currently, the treatment satisfaction for dementia is among the lowest and no drug therapy is available to cure the disease. With a rapidly ageing global population, the development of dementia preventive and therapeutic drugs is critical. Cognitive impairment has been linked to the consumption of excess table salt, a ubiquitous food seasoning. High salt (HS) intake can also lead to hypertension. To prevent adverse health outcomes, the World Health Organization recommends limiting salt intake to less ...

Groundbreaking study reveals sympatric sloths have developed diverse strategies to adapt to their surroundings, enhancing their chances of survival in the face of environmental fluctuations

2023-05-29

Researchers have shed light on the activity patterns and behavioral adaptations of two sympatric sloth species, Bradypus variegatus and Choloepus hoffmanni. This groundbreaking study, conducted in the lowland rainforests of the Caribbean coast of Costa Rica, offers valuable insights into the ecological dynamics of sloths and their ability to thrive in diverse environmental conditions. Faced with the challenge of studying the elusive nature of sloths, Dr. Rebecca Cliffe Founder and Executive Director of The Sloth Conservation Foundation ...

Super low-cost smartphone attachment brings blood pressure monitoring to your fingertips

2023-05-29

Engineers at the University of California San Diego have developed a simple, low-cost clip that uses a smartphone's camera and flash to monitor blood pressure at the user’s fingertip. The clip works with a custom smartphone app and currently costs about 80 cents to make. The researchers estimate that the cost could be as low as 10 cents apiece when manufactured at scale. The technology was published May 29 in Scientific Reports. Researchers say it could help make regular blood pressure monitoring easy, affordable and accessible to people in resource-poor ...

Robot centipedes go for a walk

2023-05-29

Osaka, Japan – Researchers from the Department of Mechanical Science and Bioengineering at Osaka University have invented a new kind of walking robot that takes advantage of dynamic instability to navigate. By changing the flexibility of the couplings, the robot can be made to turn without the need for complex computational control systems. This work may assist the creation of rescue robots that are able to traverse uneven terrain. Most animals on Earth have evolved a robust locomotion system using legs that provides them with a high degree of mobility over a wide range of environments. Somewhat disappointingly, engineers who have attempted to replicate this ...

How to diagnose and manage depression in adolescents: a new review for clinicians

2023-05-29

How do you diagnose and manage depression in adolescents? A new review published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.220966 aims to help primary care clinicians address this increasingly common, yet under-detected condition, in teenagers. "Although more than 40% of people with depression experience onset before adulthood, depression remains undetected in many adolescents in Canada, and most are untreated," writes Dr. Daphne Korczak, a psychiatrist with the Hospital for Sick Children (SickKids) and the University of Toronto, Toronto, Ontario, with coauthors. "Clinicians consistently ...

New moms and dads left unprepared for parenthood by government health ‘failures’, report warns

2023-05-27

UK Government’s “outdated” public health messages are leaving new parents in the dark about what to expect after birth Some parents still smoking or drinking at the start of pregnancy, report by Children’s Alliance warns Frontline medical staff aren’t passing on key public health messages about pregnancy, authors reveal Expectant mothers and fathers are being failed by the UK Government’s “outdated” public health plans leaving them unprepared for parenthood, a new report has warned. The review by Children’s Alliance, with the University of Southampton, found that women and men are unaware of how poor personal health can impact ...

Pediatric Cancer Research Foundation announces 2023 grant recipients to accelerate discovery of new treatments for pediatric cancers

2023-05-26

The Pediatric Cancer Research Foundation (PCRF), a nonproﬁt focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced the 19 recipients of its 2023 research grants. The researchers will receive $1,730,000 in funding to explore new and safer treatments for pediatric cancers. Of the recipients, six scientists are receiving PCRF funding for the ﬁrst time. For the balance, PCRF funding will support the continuation of ongoing research projects. Grant recipients will conduct their research at top institutions across the U.S, studying various ...

A novel blood serum assay to diagnose neurodegenerative diseases

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: